Skip to main content
Clinical Trials/IRCT20131203015634N3
IRCT20131203015634N3
Recruiting
Phase 2

Comparison of the effect of oral sodium bicarbonate and tolterodine in women with symptoms of overactive bladder and acidic urine

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
over active bladder.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
36
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients referred to the gynecology clinic included all patients over 18 years of age who voluntarily and knowingly complained of overactive bladder symptoms who had these symptoms for at least 12 weeks and received no treatment, had a frequency of more than 8 times and more than 2 times nocturia, urinary pH less than 6 and lacked of relaxation. Patients under 18 years of age, urinary pH more than 6, kidney stones, stress incontinence, history of abdominal menopause surgery, heart problems, urinary tract infections, malignancies, pelvic pain, neurogenic bladder , Use of antidepressants, anticholinergics, alphablockers, beta\-3 agonists, and history of allergies to anticholinergics, sodium bicarbonate, rectocell, cystocell, and uterine prolapse, frequency Less than 8 and nocturia less than 2 in 24 hours are not included in the study.

Exclusion Criteria

  • If the patient does not want to continue taking. Allergic reaction to the drug. The patient becomes pregnant. Reluctance to continue cooperation in the project. They are excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials